Clinical Trial Update: PK/PD Study of Subcutaneous Cenderitide Infusion in CHF Patients [Phase 1]

View source ↗

Summary

Phase 1 PK/PD study evaluating subcutaneous infusion of Cenderitide (CD-NP) in heart failure patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure
• Heart Failure

Drugs mentioned

• Cenderitide (CD-NP)

Snippet

Sponsor: Nile Therapeutics | Conditions: Heart Failure, ADHF | Phase 1 | Status: COMPLETED